Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1038/nm.3081
Read article for free, from open access legal sources, via Unpaywall:
https://www.nature.com/articles/nm.3081.pdf
References
Articles referenced by this article (15)
Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.
Nat Med, (7):809-810 2013
MED: 23836213
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Nat Med, (3):396-404 2012
MED: 22306733
Crystal structure of the BMP-2-BRIA ectodomain complex.
Nat Struct Biol, (6):492-496 2000
MED: 10881198
Structure of the ternary signaling complex of a TGF-beta superfamily member.
Proc Natl Acad Sci U S A, (20):7643-7648 2006
MED: 16672363
Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily.
Science, (5068):369-373 1992
MED: 1631557
An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2.
Nature, (6385):430-434 1992
MED: 1641027
Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily.
Proc Natl Acad Sci U S A, (2):878-883 1996
MED: 8570652
Bosukonda, D. Screening method for bone marrow morphogenic mimetics. Patent application number: PCT/US00/42657. WIPO publication WO 2002/039118. (2002).
Duan, Z. et al. J. Huazhong Univ. Sci. Technolog. Med. Sci. 28, 426–430 (2008).
Lock, J. & Liu, H. Int. J. Nanomedicine 6, 2769–2777 (2011).
Show 5 more references (10 of 15)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Sci Rep, 9(1):13446, 17 Sep 2019
Cited by: 11 articles | PMID: 31530856 | PMCID: PMC6748948
Hypoxia-sensitive pathways in inflammation-driven fibrosis.
Am J Physiol Regul Integr Comp Physiol, 307(12):R1369-80, 08 Oct 2014
Cited by: 29 articles | PMID: 25298511
Review
Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.
Br J Pharmacol, 171(15):3620-3632, 01 Aug 2014
Cited by: 53 articles | PMID: 24758361 | PMCID: PMC4128061
Review Free full text in Europe PMC
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.
Nat Med, 19(7):809-810, 01 Jul 2013
Cited by: 8 articles | PMID: 23836213
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Nat Med, 18(3):396-404, 05 Feb 2012
Cited by: 147 articles | PMID: 22306733 | PMCID: PMC3998727
Bone Morphogenic Protein. Preface.
Vitam Horm, 99:xiii-xiv, 01 Jan 2015
Cited by: 1 article | PMID: 26279382
Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
Drug Discov Today, 11(9-10):405-411, 01 May 2006
Cited by: 32 articles | PMID: 16635802
Review
